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Live-cell monitoring of periodic gene expression
in synchronous human cells identifies Forkhead
genes involved in cell cycle control
Gavin D. Granta, Joshua Gamsbya, Viktor Martyanova, Lionel Brooks 3rda, Lacy K. Georgea,
J. Matthew Mahoneya, Jennifer J. Lorosa,b, Jay C. Dunlapa, and Michael L. Whitfielda
a

Department of Genetics and bDepartment of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover,
NH 03755

ABSTRACT We developed a system to monitor periodic luciferase activity from cell cycle–
regulated promoters in synchronous cells. Reporters were driven by a minimal human E2F1
promoter with peak expression in G1/S or a basal promoter with six Forkhead DNA-binding
sites with peak expression at G2/M. After cell cycle synchronization, luciferase activity was
measured in live cells at 10-min intervals across three to four synchronous cell cycles, allowing
unprecedented resolution of cell cycle–regulated gene expression. We used this assay to
screen Forkhead transcription factors for control of periodic gene expression. We confirmed
a role for FOXM1 and identified two novel cell cycle regulators, FOXJ3 and FOXK1. Knockdown of FOXJ3 and FOXK1 eliminated cell cycle–dependent oscillations and resulted in decreased cell proliferation rates. Analysis of genes regulated by FOXJ3 and FOXK1 showed
that FOXJ3 may regulate a network of zinc finger proteins and that FOXK1 binds to the promoter and regulates DHFR, TYMS, GSDMD, and the E2F binding partner TFDP1. Chromatin
immunoprecipitation followed by high-throughput sequencing analysis identified 4329 genomic loci bound by FOXK1, 83% of which contained a FOXK1-binding motif. We verified
that a subset of these loci are activated by wild-type FOXK1 but not by a FOXK1 (H355A)
DNA-binding mutant.
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INTRODUCTION
The cell cycle, which governs the timing and progression of DNA
replication (S phase) and mitosis (M phase), is one of the most tightly
regulated cellular processes. Because misregulation can lead to
This article was published online ahead of print in MBoC in Press (http://www
.molbiolcell.org/cgi/doi/10.1091/mbc.E11-02-0170) on June 27, 2012.
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chromatin immunoprecipitation followed by short read sequencing; CM, culture
media; DAVID, Database for Annotation, Visualization, and Integrated Discovery;
ER, estrogen receptor; FACS, fluorescence-activated cell sorting; FOX, Forkhead
Box; GCA, Gene Centered Annotation; MACS, model-based analysis of chip-seq;
MEME, multiple em for motif elicitation; 4OHT, 4-hydroxytamoxifen; PI, propidium iodide; SE, standard error of the mean; siRNA, small interfering RNA; SM,
selection media; thy-thy, thymidine-thymidine; thy-noc, thymidine-nocodazole;
TSS, transcription start site; TTS, transcription termination site; UTR, untranslated
region.
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catastrophic cellular events such as programmed cell death or cancer, determining the key regulators and pathways controlling periodic, cell cycle–dependent gene expression is critical. Cell cycle–
regulated gene expression has been studied extensively by DNA
microarray (Cho et al., 2001; Whitfield et al., 2002; Bar-Joseph et al.,
2008), luciferase reporter assays (Hwang et al., 1995), and both timelapse and still-image microscopy (Stacey and Hitomi, 2008; Kaida
et al., 2011). Although these assays can provide extraordinary levels
of detail with regard to the number of genes measured, they are too
costly and time-consuming to use as a screening strategy for genes
that affect the regulation of periodic gene expression. To study genetic interactions between regulators and periodic gene expression,
we developed a system to measure cell cycle–driven luciferase expression in living cells over multiple synchronous cell cycles in real
time. We then used this system in conjunction with RNA interference
(RNAi) to identify novel regulators of cell cycle progression.
The ability to follow promoter-regulated luciferase activity in live
cells has been used successfully to probe the molecular nature of
both circadian rhythms (Welsh et al., 2004) and cell division in yeast
(Robertson et al., 2008). Recently a similar system has been used to
3079

show that progression through mitosis is independent of the circadian rhythm in Rat-1 fibroblasts (Yeom et al., 2010). In the case of
mammalian circadian rhythms, cells transfected with a circadianregulated promoter driving luciferase are synchronized, and luciferase activity is followed over time in a luminometer (Gamsby
et al., 2009). In addition, circadian rhythms can be followed with this
method in cells or tissue isolated from transgenic mice containing
clock genes fused to luciferase at their endogenous loci (Yoo et al.,
2004). Furthermore, RNAi has been used with this system to uncover novel components of the mammalian molecular clock (Zhang
et al., 2009).
Measurement of luciferase activity in real time allows for simpler
data collection and for greater accuracy, as the sampling intervals
are more frequent than with other methods. Furthermore, since the
measurements are nondestructive, the readings are from the same
cells throughout the experiment, thus removing the variability of
sample-to-sample comparison and greatly reducing the number of
replicates needed. Because the cells are viable during data collection, drug treatments with agents such as DNA-damage inducers
are possible throughout the experiment, allowing for great flexibility
in experimental design (Gamsby et al., 2009). In addition, since luciferase remains bound to oxyluciferin after the light-emitting reaction (Lemasters and Hackenbrock, 1977) and the media contains an
excess of luciferin, the readings obtained report the activity of newly
synthesized luciferase, giving a clearer snapshot of reporter activity.
Forkhead Box (FOX) genes form a family of transcription factors
found in species from yeast to human and are involved in a number
of different cellular processes, including cell cycle progression, organ development, and oxidative stress responses (Huang and
Tindall, 2007). The FOX family of transcription factors comprises
>30 genes in humans, all of which contain a monomeric DNA-binding domain (Kaestner et al., 2000).
The transcription factor FOXM1 is known to regulate gene transcription during the transition from G2 to M phase of the cell cycle
and to be overexpressed in cancer cells (Wierstra and Alves, 2007).
RNAi-mediated knockdown in U2OS or BT-20 human cells results in
decreased mitotic indexes and a concomitant increase in the number of cells in G2 (Laoukili et al., 2005; Wonsey and Follettie, 2005).
In G2, FOXM1 up-regulates the expression of Cdc25B, cyclin B1,
Aurora B kinase, Plk1, CENPA, CENPB, and survivin. In addition,
FOXM1 is progressively phosphorylated by a number of kinases,
including PLK1 and cyclin B/cdk1 complexes (Fu et al., 2008), as well
as by cyclin A/CDK2 or cyclin E/CDK2 complexes (Wierstra and
Alves, 2007), which then leads to its degradation by the APC/C after
targeting by CDH1 at the end of mitosis (Laoukili et al., 2008). These
phosphorylation events restrict the period of FOXM1 DNA-binding
activity to the G2 and M phases of the cell cycle. Given this, a reporter driven by a synthetic promoter that is responsive to FOXM1
activity will accurately report the G2/M-specific activity of FOXM1.
E2F1 is a member of the E2F family of transcription factors, which
control the expression of genes involved in apoptosis, differentiation,
DNA synthesis, and mitosis (Shibutani et al., 2008). E2F1 is specifically
involved in the transition from G1 to S phase of the cell cycle (Johnson
et al., 1994). Of the many regulatory mechanisms that control E2F1
activity during the cell cycle, two of the best characterized are the
binding of E2Fs to the retinoblastoma family of proteins and cell cycle
phase–specific degradation (Marti et al., 1999). In addition, cell cycle
regulation of the E2F1 promoter restricts expression to the correct
cell cycle phase. The E2F1 promoter is autoregulated by active E2F1
during G1/S (Johnson et al., 1994), driving a rapid increase of active
E2F1. After the period of E2F1 activity is complete, E2F7 and E2F8
bind to and repress the E2F1 promoter (Li et al., 2008; Zalmas et al.,
3080 | G. D. Grant et al.

2008). The combination of E2F1 promoter autoregulation and E2F7
and E2F8 repression restricts the promoter activity to G1/S.
To exploit the well-characterized, cell cycle–controlled oscillatory
behavior of E2F1 at G1/S and FOXM1 at G2/M, we used constructs
with either a minimal E2F1 promoter or FOX DNA consensus binding sites (Furuyama et al., 2000) driving luciferase expression. Using
cell cycle synchronization protocols combined with selective small
interfering RNA (siRNA) knockdowns, we followed the G1/S or G2/M
reporters and identified two genes necessary for proper oscillation
of cell cycle–regulated gene expression in human cells, FOXJ3 and
FOXK1 (myocyte nuclear factor). We identified target genes regulated by FOXJ3 and FOXK1. We also identified the genomic loci
bound by FOXK1 with chromatin immunoprecipitation followed by
short read sequencing (ChIP-seq), which showed that FOXK1 might
have a direct role in regulating the transcription of key cell cycle effectors. We identified a FOXK1 DNA motif present in 81.6% of the
intersecting ChIP-seq peaks identified by MACS, and we show that
select ChIP-seq peaks are responsive to FOXK1 in the live-cell luciferase reporter assay. These results show that FOXK1 regulates an
expansive network of genes, including many that are critical for cell
cycle progression, most notably DHFR, TYMS, GSDMD, and
TFDP1.

Results
We designed experiments to identify Forkhead transcription factors
that contribute to the periodic oscillation of cell cycle–regulated
genes. We optimized thymidine-thymidine (thy-thy) and thymidinenocodazole (thy-noc) cell cycle synchronizations (Whitfield et al.,
2002) in U2OS cells, a human osteosarcoma line widely used for cell
cycle studies (Fu et al., 2008; Laoukili et al., 2008). To easily and inexpensively monitor cell cycle progression in living cells across multiple, synchronous cell cycles, we developed stable cell lines that
expressed cell cycle–regulated luciferase reporters with peak activity in either G1/S or G2/M.

Development of real-time cell cycle reporter assay
for periodic gene expression
Previous studies reported that FOXM1 activity oscillates in a cell
cycle–dependent manner (Laoukili et al., 2005, 2008; Fu et al.,
2008). To report FOXM1 activity, we used a construct that has six
Forkhead DNA-binding domains (6xDB) that drive expression of luciferase. Because estrogen receptors (ERs) localize to the nucleus
upon ligand binding and this property can be exploited to artificially
shuttle proteins to the nucleus (Chandriani et al., 2009), we designed
a construct that expresses a fusion of FOXM1 and ER (FOXM1-ER).
We then transiently transfected U2OS cells with both the 6xDB and
FOXM1-ER constructs and confirmed by chromatin immunoprecipitation that FOXM1 is bound to the FOX-specific consensus sequences after addition of 4-hydroxytamoxifen (4OHT; Supplemental
Figure S1D, inset). Addition of ER ligand 4OHT induced nuclear
translocation of the FOXM1-ER fusion protein, which elicited an increase of luciferase activity beginning between 7.5 and 9 h, with
peak luciferase expression around 34 h (Supplemental Figure S1D).
Luciferase activity increased approximately eightfold in the 4OHTtreated cells compared with the vehicle-only negative control cells.
Thus FOXM1 binds directly to FOX-specific DNA-binding sites and
activates the 6xDB construct in our U2OS system.
After synchronization of U2OS cells stably expressing the 6xDB
reporter at G1/S by thy-thy synchronization, FOXM1 displays peak
levels and increased phosphorylation in late G2 (Figure 1A, top), and
luciferase activity peaks concomitantly (Figure 1B). As expected,
FOXM1 phosphorylation peaks during G2 before FOXM1 is
Molecular Biology of the Cell

FIGURE 1: Synchronous U2OS cells show periodic oscillation of G1/S and G2/M luciferase reporters. (A) Anti-FOXM1
Western blot in synchronous 6xDB U2OS cells shows periodic expression and phosphorylation of FOXM1 protein.
Samples were taken every 2 h after release from the second thymidine block. Peak FOXM1 phosphorylation occurs at
12–14 and 30–32 h after release. GAPDH is shown as a loading control. (B) Baseline-subtracted luciferase activity in cells
expressing 6xDB peaks at 12–14 and 30–32 h. Luciferase activity was read every 10 min from each of four replicate
plates. Error bars represent the SE of the quadruplicate samples. (C) The percentage of cells in G1 and G2/M based on
PI staining. FlowJo was used to calculate the percentage of cells in each phase. (D) Western blot showing E2F1 levels in
synchronous hE2F1 U2OS cells. Samples were taken every 2 h after release from the second thymidine block. GAPDH is
shown as a loading control. Arrow indicates the E2F1 band. (E) Baseline-subtracted luciferase activity in cells expressing
hE2F1-luciferase (hE2F1-luc) peaks at 20–24 h postrelease. Error bars represent the SE of quadruplicate samples. (F) The
percentage of cells in G1 or G2/M based on PI staining. Cells were plated and treated in parallel for A–C and D–F.

degraded after mitosis (Figure 1A, hours 18 and 34). Given that
phosphorylation of FOXM1 is required for its activity, these data also
suggest that active FOXM1 is driving FOX DNA consensus site expression peaks, since the phosphorylation profile of FOXM1 is in
phase with peak activity of 6xDB. Furthermore, the luciferase reporter shows minimal activity in late G1 and early to mid S phase,
which is consistent with previously reported findings (Luscher-Firzlaff
et al., 2006). The two peaks of luciferase activity correspond to G2/M
phase of sequential cell cycles as determined by fluorescence-activated cell sorting (FACS) analysis (Figure 1C). A gradual dampening
of the rhythm occurs over time as the cell population loses synchrony,
as evidenced by increased standard error of the mean (SE; Figure
1B) and a decrease in the maximal percentage of G2/M cells in the
second cell cycle (Figure 1C). These data show that peak expression
of the 6xDB reporter faithfully reports late G2 and M phase in the
U2OS cell cycle.
Precise analysis of cell cycle progression requires markers at
more than one phase, so we also generated cells that stably express
luciferase under the control of a minimal human E2F1 promoter
(hE2F1) to report the G1/S transition. Cells were analyzed by Western blot and luciferase activity in a manner similar to FOXM1. Peak
expression of E2F1 occurs at 2 and 22 h after release from a thy-thy
block as seen via Western blot (Figure 1D), which corresponds to
peak luciferase activity (Figure 1E) and with the G1 phase of the cell
cycle, as determined by FACS profiling (Figure 1F).
To confirm the cell cycle dependence of the oscillations in E2F1
and FOXM1, we used a thy-noc synchronization method to arrest
the cells in M phase instead of G1/S (Figure 2). As expected, the two
synchronization methods yield peak luciferase activity that is antiphasic, a result of the two synchronization methods blocking at two
opposing points in the cell cycle. Both synchronization methods
yield cell cycle periods between 18 and 22 h. These data indicate
Volume 23 August 15, 2012

that the oscillations in the hE2F1 cell line are reporting late G1 and
early S phase in U2OS cells.
As a negative control for the luciferase reporters, we generated stably transfected U2OS cells with either no promoter (pGL3Basic with no insertions) or a constitutive promoter (pGL3-Control;
Supplemental Figure S2). No pGL3-Basic or pGL3-Control cell
lines showed significant oscillations with periods close to that of
the cell cycle, confirming that the oscillations in 6xDB and hE2F1
cell lines are not caused by cell line production or synchronization
method.

Numerous Forkhead genes are involved in proper
cell cycle regulation
The ability to monitor simultaneously and with precision the different cell cycle stages suggested to us that this system would be useful in screening potential cell cycle regulators. As a proof of principle, we treated 6xDB and hE2F1 cells with siRNAs specific to FOXM1
and then synchronized the treated cells in G1/S with a thy-thy block
(Supplemental Figure S1). Knowing that cells treated with siRNAs
targeting FOXM1 have aberrant mitosis and undergo mitotic catastrophe (Wierstra and Alves, 2007), we anticipated dampened or lost
oscillations in both markers, assuming the degree of knockdown
was sufficient; this was observed (Figure 3, A and B). Empowered by
these positive controls and the lack of cell cycle effects in negative
controls (see Supplemental Figure S2, A and B), we screened siRNAs against five FOX genes. Four were implicated in cell cycle control in one of four genome-wide RNAi screens for cell cycle defects
(FOXA2, FOXJ3, FOXK1, and FOXL2; Mukherji et al., 2006; Root
et al., 2006; Kittler et al., 2007; Rines et al., 2008), and one showed
periodic mRNA expression during the cell cycle in one of three genome-wide mRNA profiling experiments for cell cycle-regulated
genes (FOXP1; G.D.G., L.K.G., and M.L.W., unpublished data).
Periodic cell cycle gene regulation

| 3081

to cell cycle arrest and not to a direct interaction between the reporter and FOXK1 proteins, since FOXK1 does not appear to target
PLK1 directly (see ChIP-seq data presented later).
Consistent with this, all siRNAs against FOXJ3, FOXK1, or
FOXM1 resulted in significantly reduced proliferation rates compared with controls (Figure 5). A cell viability assay revealed no noticeable increases in dead cells between the control and the siRNAtreated cells, indicating that the decrease in cell numbers reflects a
decrease in proliferation rate. Disruption of cell cycle progression by
these FOX-specific siRNAs was further confirmed by FACS analysis
of propidium iodide (PI)–stained cells, which revealed an increase in
the number of cells in G1 (Figure 5A). These data indicate that in
addition to FOXM1, the Forkhead Box transcription factors FOXJ3
and FOXK1 have important roles in regulating cell proliferation. This
also suggests that an extensive network of Forkhead transcription
factors regulates cell cycle progression.

Transcriptional targets of FOXJ3 and FOXK1

FIGURE 2: Luciferase activity from hE2F1-Luc and 6xDB-Luc
reporters are antiphasic after thy-thy and thy-noc synchronizations.
(A) Baseline-subtracted luciferase activity over 54 h after thy-thy
synchronization in cells expressing 6xDB-Luc and hE2F1-Luc. Raw data
are shown as an inset at the upper right. (B) Baseline-subtracted
luciferase activity in cells expressing hE2F1-Luc and 6xDB-Luc over
78 h after a thy-noc synchronization. Mean values of quadruplicate
samples are shown. Raw data are shown as an inset at the upper
right.

Overlap between the different RNAi screens and mRNA expression
data was minimal, resulting in each gene being identified in only a
single screen. FOXM1, a known regulator of cell cycle gene expression, was only identified in Whitfield et al. (2002).
In independent experiments, knockdown of FOXJ3 and FOXK1
greatly decreased the cell cycle–dependent oscillations in both
6xDB and hE2F1 cell lines (Figure 3, E–L). FOXL2 was found not to
be expressed in U2OS cells and, consistent with this finding, had no
cell cycle phenotype (unpublished data). Quantitative PCR demonstrated knockdown efficiencies of 90 and 60% of wild-type gene
expression levels for FOXJ3 and FOXK1, respectively, showing that
even a partial loss of function significantly affected periodic gene
expression (Figure 3M). Knockdown of the remaining Forkhead proteins gave intermediate phenotypes; detailed characterization will
be reported elsewhere.
We then used a human PLK1 promoter luciferase reporter construct to show that loss of G2/M oscillations also occurred with an
endogenous human G2/M promoter. U2OS cells stably expressing
this reporter faithfully reproduced the same periodic, G2/M-specific
oscillation and phasing of luciferase activity as the synthetic 6xDB
Forkhead Box promoter construct (Figure 4A). RNAi knockdown with
the two independent siRNAs against FOXJ3 (Figure 4, B and C) and
FOXK1 (Figure 4, D and E) shows a loss of cell cycle phase–specific
luciferase activity. This suggests that loss of G2/M oscillations is due
3082 | G. D. Grant et al.

To identify potential gene targets of FOXJ3 and FOXK1, we performed three independent siRNA knockdowns for these two genes
in asynchronous U2OS cells. As a negative control, we used an
siRNA that does not target any known cellular mRNAs (siGENOME
Non-Targeting siRNA #2). We collected time points before siRNA
treatment (0 h) and at 12, 24, 48, and 72 h after knockdown. We
prepared RNA from each time point and analyzed it using DNA microarray hybridization. We selected 1651 genes that changed at
least 2.14-fold from the 0 time point in at least three samples and
clustered them hierarchically (Figure 6A).
Multiple clusters of coordinately regulated genes were evident
after siRNA knockdown. The genes showing the most consistent
decrease in expression were those associated with cell division. As
expected, these genes showed decreased expression in both
FOXJ3 and FOXK1 treatments, and there is an enrichment of wellcharacterized cell cycle–regulated genes (Figure 6E). These include
genes known to cause cell cycle defects after knockdown (Mukherji
et al., 2006; Root et al., 2006; Kittler et al., 2007; Rines et al., 2008),
as well as genes expressed in S (RRM2) and G2/M phases (CENPE,
PLK1, and STK6; Whitfield et al., 2002). Of the 52 genes with
decreased expression in this cluster, 35 (69%) were cell cycle regulated in HeLa cells (Whitfield et al., 2002). Analysis of the 52 genes
in this cluster by the Database for Annotation, Visualization and Integrated Discovery (DAVID; Dennis et al., 2003; Huang da et al.,
2009) showed enrichment for genes associated with cell cycle–specific processes (Supplemental Table S1). A second general group of
genes included the immediate early genes that are increased by
serum stimulation (Iyer et al., 1999; Figure 6C) and decrease with
time after treatment in both the siRNA knockdowns and the mock
treatment.
To identify genes that might be specifically regulated by either
FOXJ3 or FOXK1, we examined the data for genes whose expression levels changed due to the knockdown of one Forkhead but not
the other. As expected, FOXJ3 mRNA levels were decreased by the
siRNA specific for FOXJ3 but not by the siRNA for FOXK1 or the
control siRNA. Examination of genes that cluster with FOXJ3 shows
that 9 of 32 genes are uncharacterized zinc finger proteins (Figure
6D), whereas others include a ring finger protein (RNF138) and a
putative RNA-binding protein (RBM25). This suggests that FOXJ3
might have a role in regulating this subset of zinc finger DNA and/
or RNA-binding proteins that might be involved in cell cycle progression (Supplemental Table S1). We also uncovered a group of
genes (Figure 6B) that showed increased expression after FOXJ3
knockdown and decreased expression in the FOXK1 knockdown,
Molecular Biology of the Cell

indicating that these genes might be repressed by FOXJ3
activity and activated by FOXK1. This set of genes could
represent indirect FOXK1 targets, although many of these
genes do not have a clear role in cell cycle regulation.
However, there is a significant enrichment for proteins
involved in cell signaling (p = 1.02 × 10−4; Supplemental
Table S1) as well as secreted, extracellular matrix proteins
(p = 0.001).

FOXK1 binds to the promoter and regulates
key cell cycle regulators
To understand how knockdown of FOXK1 results in cell
cycle arrest, we sought to identify direct targets of FOXK1
by analyzing the DNA regions bound by endogenous
FOXK1 by ChIP-seq using two independent antibodies
against FOXK1 (adequate antibodies were not available
for FOXJ3). The DNA fragments from each independent
ChIP were sequenced independently. ChIP-seq of FOXK1
using the first antibody (AB G22; Santa Cruz Biotechnology) resulted in 58 million mapped sequence reads
(2.1 million unmapped), and ChIP-seq using the second
antibody (AB134550; Santa Cruz Biotechnology) resulted
in 65 million mapped reads (2.2 million unmapped; Human
Genome build 19). Enriched peaks were identified in each
data set independently using MACS (Zhang et al., 2008;
Liu et al., 2011; mfold 15, p < 0.001), which resulted in
7513 peaks in AB G22 and 6225 peaks in AB1344550. For
a conservative estimate of FOXK1 binding, we focused our
analysis on those sequences that were found in both experiments. Taking the intersection resulted in 4329 shared
MACS peaks (Supplemental Table S2). Each includes the
intersecting DNA region under the peaks, and we refer to
these as “FOXK1 genomic loci.” We determined the distribution of these 4329 shared FOXK1 binding loci in the genome using the cis-regulatory element annotation system
(CEAS; http://liulab.dfci.harvard.edu/CEAS; Zhang et al.,
2008) implemented in Cistrome (www.cistrome.com). The
4329 genomic loci map to 2865 RefSeq mRNAs representing 1772 unique human genes. We found significant enrichment of genomic loci within 3 kb upstream of the transcriptional start site (6.1%, p = 1.7 × 10−53; Figure 7A), and
36.6% of the genomic loci were found in introns (p = 1.5 ×
10−11). We found 51.7% of the FOXK1 loci in distal intergenic regions (defined in this analysis as >3 kb from the

FIGURE 3: FOXM1, FOXJ3, and FOXK1 are necessary
for periodic gene expression in synchronous U2OS cells.
(A–L) Raw luciferase activity levels for cells expressing
hE2F1-Luc (A, C, E, G, I, K) or 6xDB-Luc (B, D, F, H, J, L)
treated with the indicated siRNAs and then synchronized by
a thy-thy arrest (diagramed in Supplemental Figure S1B).
Luciferase activity was measured every 10 min over 72 h
after release from the second thymidine arrest. Cells treated
with siRNAs against FOXJ3, FOXK1, or FOXM1 show
decreased cell cycle–dependent oscillation of luciferase
activity relative to control siRNA treatment. All graphs are
the mean of a minimum of three samples; error bars are SE.
The y-axes have been set to the same value based on
luciferase levels in C (hE2F1) and D (6xDB). (M) Relative
mRNA expression levels for siRNAs to FOXJ3 and FOXK1.
Control siRNA (Dharmacon siControl #2) expression levels
have been set to 100%. Expression levels are normalized to
GAPDH RNA levels.
Volume 23 August 15, 2012
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FIGURE 5: FOXJ3 and FOXK1 knockdown results in accumulation of
G1 cells and impaired proliferation. (A) Percentages of cells in each
cell cycle phase as determined by PI staining. Cells were assayed 72 h
after siRNA transfection. Both FOXJ3 and FOXK1 cells show an
increase in the percentage of cells in G1. Error bars are SE from
triplicate samples. All p values of treated cells compared with
siControl #2 are <0.05 except FOXK1-1 (p = 0.0538). FlowJo was used
to calculate the percentages of cells in each phase. (B) A 72-h
proliferation curve shows a proliferation defect in U2OS cells treated
with siRNAs targeting FOXJ3 or FOXK1. Error bars are SE of triplicate
samples. Indicated p values are <0.05 (*), 0.01 (*), or 0.005 (***) when
compared with the percentage of cells in G1 of the SiControl
#2–treated cells. (C) Percentage of dead cells, as determined by
trypan blue staining, from the proliferation curve in B.

FIGURE 4: The cell cycle–dependent oscillations of the human PLK1
gene promoter are ablated after the knockdown of FOXK1 or FOXJ3.
Luciferase activity was measured every 10 min over 72 h after release
from the second thymidine arrest, concomitant with siRNA
knockdowns as indicated. (A) The cell cycle–associated oscillations of
3084 | G. D. Grant et al.

luciferase activity driven by the human PLK1 gene promoter after
transfection with a control siRNA. (B–E) U2OS cells treated with two
independent siRNAs against FOXJ3 (B, C) or FOXK1 (D, E) showed
decreased cell cycle–dependent oscillation of luciferase activity. All
graphs are the mean of at least three samples; error bars are SE. The
y-axes have been set to the same value based on luciferase levels in A.
Molecular Biology of the Cell

FIGURE 6: Expression profiling of FOXJ3 and FOXK1 siRNA knockdowns in asynchronous U2OS cells. (A) Hierarchical
clustering of the 1651 genes that changed at least 2.14-fold on three arrays relative to time zero. The first three columns
are zero time points (blue line), the fourth is the zero average, and each time point for the indicated siRNA is indicated
by the blue triangle (12, 24, 48, and 72 h). All three experiments were performed in parallel, and therefore the same
zero time points are used for each siRNA knockdown. (B) Secreted extracellular matrix gene cluster that shows
increased expression after FOXJ3 knockdown and decreased expression after FOXK1 knockdown. (C) The immediate
early genes (Iyer et al., 1999; Chang et al., 2004). (D) FOXJ3 cluster shows a decrease in FOXJ3 mRNA, specifically in
cells treated with the FOXJ3 siRNA, and includes a large number of zinc finger proteins. (E) Cell cycle cluster that shows
decreased expression in both FOXJ3 and FOXK1 knockdowns. We find that 67.3% of the genes in this cluster are cell
cycle regulated in HeLa cells.
Volume 23 August 15, 2012
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FIGURE 7: FOXK1 binds to the promoters of an expansive set of genes critical for cell cycle progression. (A) CEAS
analysis of the overlapping sequences found in the two antibody ChIP-seq analyses shows an enrichment in promoters
(3000 base pairs upstream of the transcriptional start site) and a reduction of intronic FOXK1-binding loci relative to
background. (B) Analysis of the 4329 overlapping FOXKI loci for overrepresented sequence elements identifies two
significantly enriched FOXK1-like DNA-binding motifs. We find that 83.4% of the FOXK1 genomic loci contain at least
one of the motifs; 51.3% of the FOXK1 loci contain both motifs. (C) Comparison of all cell cycle–regulated genes from
Whitfield et al. (2002) with FOXK1 loci shows a higher percentage of occupancy of the promoters of genes with peak
expression in G1/S and S phase. (D) Comparison of the genes that result in a cell cycle arrest in one of four genome-wide
siRNA screens (Mukherji et al., 2006; Root et al., 2006; Kittler et al., 2007; Rines et al., 2008) linked to FOXK1 ChIP-seq
loci shows higher percentage of occupancy in genes that result in an S or G2 phase arrest. (E) Multiple FOXK1-binding
loci (thick black bars) are found in the promoter and introns of the TFDP1 gene. FOXK1-like DNA-binding motifs found
in each locus are indicated (thin black bars). (F) A single intronic FOXK1 binding locus with multiple FOXK1-like DNAbinding motifs (thin black bars) is found in DHFR. Direction of transcription is indicated for each gene. (G) Change in
gene expression for TFDP1 mRNA in the siRNA knockdown experiment (Figure 6) shows a 2.6-fold drop in TFDP1
mRNA levels after FOXK1 knockdown. (H) The gene expression data for FOXK1 target genes DHFR, TFDP1, TYMS, and
GSDMD are shown from the mock and FOXK1 siRNA knockdown. Each is linked to the FOXK1 genomic loci found by
ChIP-seq. CEAS was used to determine the percentage coverage for each region relative to the TSS of gene models,
TTS, or within the gene (right). Those that have peak expression levels in G1 or S as determined in Whitfield et al. (2002)
or that result in a G1- or S-phase arrest when knocked down in one of three genome-wide siRNA screens (Mukherji et al.,
2006; Root et al., 2006; Kittler et al., 2007) are indicated (the full list is available in Supplemental Tables S3 and S4).
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transcription start site [TSS] or transcription termination site [TTS]),
similar to what would be expected by chance (50%). The percentage of FOXK1 loci in 5′ untranslated regions (UTR), coding exons, or
3′ UTRs of genes was minimal (Figure 7A).
To determine whether the genomic loci bound by FOXK1 were
enriched for the published FOXK1 consensus sequence motif
TAAACA (Tsai et al., 2006), we analyzed all 4329 FOXK1 loci for
enriched binding sites. We found that 83.4% of the FOXK1 loci contain a FOXK1-like consensus motif. Repeat sequences in the ChIPseq intersecting sequences were masked using RepeatMasker
Open-3.0. (www.repeatmasker.org), and significant motifs with high
similarity to the FOXK1 motif were identified using the MEME Suite
of programs (Bailey et al., 2009). The MEME-ChIP algorithm (Bailey,
2011; Machanick and Bailey, 2011) identified 15 motifs that were
overrepresented in repeat masked FOXK1 genomic loci. These motifs were then compared with the FOXK1 consensus motif using
STAMP (Mahony and Benos, 2007). A motif with consensus sequence AKAAACA was the best match to the FOXK1 motif (with an
E value of 1.1 × 10−08) and found in 53% of the FOXK1 loci (Figure
7B). A second motif with consensus site ACAAAYAY was the secondbest match (with an E value of 3.6 × 10−05) and was found in 81.6%
of the loci (Figure 7B). When the two motifs are considered together,
51.3% of the loci contain both motifs, and 83.4% of the loci contain
at least one of these two motifs.

Genes regulated by FOXK1 genomic loci
We sought to identify genes near FOXK1 genomic loci that are
cell cycle regulated in HeLa cells (Whitfield et al., 2002) or show
a cell cycle defect in a collation of genome-wide siRNA screens for
cell cycle phenotypes (Mukherji et al., 2006; Root et al., 2006; Kittler
et al., 2007; Rines et al., 2008). To determine whether there was an
enrichment of FOXK1 loci near cell cycle–regulated genes, we compared the genes associated with FOXK1 loci as determined by Gene
Centered Annotation (GCA) to the list of cell cycle–regulated genes
in HeLa cells. We mapped the 1134 cell cycle–regulated clones of
Whitfield et al. (2002) to 688 unique Entrez Gene IDs. Of these
genes, 48 (7%) were linked to FOXK1 ChIP-seq loci by GCA (Supplemental Table S3). Analysis of the GCA gene models that have FOXK1
bound shows an increase in the percentage occupancy of promoters
(a measure of how much of each promoter was recovered by
ChIP-seq) for genes expressed in G1 and S phases (Figure 7C).
To determine whether there was a similar pattern in the siRNA
screen data sets, we identified those genes linked to FOXK1 loci
that also showed a cell cycle phenotype (arrest at a specific cell cycle
phase or endoreduplication) after knockdown. Of the 2585 genes
that showed a cell cycle arrest phenotype in at least one of the four
genome-wide siRNA screens (Mukherji et al., 2006; Root et al.,
2006; Kittler et al., 2007; Rines et al., 2008), 230 (9%) were linked by
GCA to a FOXK1 ChIP-seq locus (Supplemental Table S4). Again,
we found enrichment of genes that give an arrest in S phase but also
for genes that resulted in an arrest in G2. Of interest, genes that arrest cells in G0/G1 have lower percentage occupancy than genes
that give an arrest in S, G2, or M phase (Figure 7D).
Those genes associated with FOXK1 ChIP loci that have peak
expression in G1/S include RUNX1, NPAT, C21orf90, and DDX12,
and those with peak expression in S phase include TYMS, DHFR,
ABCC5, EFHC1, MBD4, HIST1H2AC, and HIST1H4H, suggesting
that FOXK1 contributes to G1- and S-phase gene expression. Genes
with peak expression in G2 and M phases include TUBB, CDC27,
GAS6, KIF23 and CEP70. Those associated with FOXK1 ChIP-seq
loci whose genes gave S-phase arrest in genome-wide siRNA
screens included HIST1H2B, NPAT, GSDMD, RPS3A, and the E2F
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binding partner TFDP1 (Figure 7E). Four of these genes (DHFR,
TYMS, GSDMD, and TFDP1) also showed decreased mRNA expression upon FOXK1 siRNA knockdown (Figure 7G-H). The full data are
available in Supplemental Tables S3 and S4.
TFDP1 shows a modest 2.6-fold decrease in mRNA expression
levels after FOXK1 knockdown (Figure 7, G and H). Knockdown of
TFDP1 by RNAi is known to result in cell cycle arrest (Masuhiro et al.,
2008) and is embryonic lethal when it is knocked out in mice (Kohn
et al., 2003). Consistent with this finding, our hE2F1 reporter failed
to oscillate after FOXK1 knockdown. To better resolve the location
of FOXK1 binding in the TFDP1 promoter, we examined the MACS
peaks in the two independent ChIP-seq experiments (Figure 7E).
We found FOXK1-binding loci in the TFDP1 promoter just upstream
of the TSS and within the second, third, and fourth introns of the
TFDP1 gene (Figure 7E and Supplemental Figure S4). Each of these
loci contained multiple FOXK1 consensus motifs as determined by
MEME. The FOXK1 ChIP-seq locus identified in the promoter by
MACS is 621 base pairs upstream of its TSS (Figure 7E) and contains
multiple FOXK1 motifs (Figure 7E).
In an attempt to phenocopy the FOXK1-knockdown phenotype
with a FOXK1-regulated gene, we knocked down TFDP1 in cells
expressing the PLK1-Luc reporter. As expected, the loss of TFDP1
expression ablates G2/M-specific luciferase activity driven by the
human PLK1 promoter (Supplemental Figure S3). Therefore the loss
of TFDP1, and potentially multiple other cell cycle–regulated genes
bound by and responsive to FOXK1, can result in a similar cell cycle
arrest upon siRNA knockdown.
We also examined DHFR, which shows peak expression in S
phase and has decreased mRNA levels 72 h after FOXK1 siRNA
knockdown (Figure 7H). We found a strong FOXK1 binding locus in
the second intron of the gene (Figure 7F) but no evidence for binding in the DHFR promoter. Consistent with this result, we found that
a DHFR promoter–luciferase reporter is not responsive to FOXK1
overexpression (see later discussion).
The 4329 FOXK1 genomic loci map to 1772 unique human
genes (most genes were associated with multiple FOXK1 genomic
loci), of which 1303 genes passed basic quality filtering in our
FOXK1 siRNA–knockdown DNA microarray analysis. To identify
genes linked to FOXK1 genomic loci that changed expression
upon FOXK1 siRNA knockdown, we divided genes into groups
using idealized expression vectors (see Materials and Methods)
representing decreased or increased expression in the FOXK1
siRNA–knockdown time course (Supplemental Figure S5). Examination of the highest-confidence groups shows that 37% (494
genes) have a specific decrease in expression after FOXK1 knockdown relative to mock and 17.5% (228 genes) show an increase in
expression (Supplemental Figures S5 and S6). Therefore FOXK1
likely acts as both an activator and a repressor of gene expression,
depending on context.
Thus we propose that FOXK1 is a key regulator of an expansive
set of critical cell cycle genes that includes TFDP1, DHFR, TYMS,
GSDMD, and the replication-dependent histone mRNAs. The elimination of either TFDP1 or GSDMD results in a G1- or S-phase arrest,
and loss of either could therefore result in the phenotype we initially
identified in the LumiCycle assay.

FOXK1 can transcriptionally activate key cell
cycle–regulated genes
To determine whether FOXK1 can activate target cell cycle promoters identified by ChIP-seq, we determined the ability of FOXK1
overexpression to affect luciferase activity from reporters driven by
the GSDMD promoter (GSDMD-Luc, 1000 base pairs upstream of
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Promoter
construct

0–24 h

24–48 h

48–72 h 72–96 h 96–120 h

GSDMD

0.599

0.021

0.014

0.019

0.034

DHFR

0.919

0.638

0.400

0.432

0.527

ACAP3

0.012

0.013

0.029

0.041

0.013

Cep72a

0.004

0.003

0.001

0.002

0.063

RPS6KB1

0.645

0.002

0.007

0.016

0.026

TFDP1

0.727

0.003

0.006

0.065

0.099

Parp10

0.764

0.004

0.265

0.782

0.641

Readings were binned and averaged in 24-h windows. One-way ANOVAs
were calculated for wild-type FOXK1 vs. DNA binding–domain mutant FOXK1
(H355A) for the quadruplicate samples that were averaged in Figures 8 and 9.
a
Due to technical issues, Cep72 was performed in triplicate. Bold indicates
p < 0.05.

TABLE 1: Luciferase assay p values.

sufficient to drive transcription when placed upstream of the transcription start site.

FOXK1 genomic loci can drive luciferase activity
and are activated by FOXK1 overexpression

FIGURE 8: Wild-type FOXK1 activates the gasdermin D promoter
(GSDMD-luc), whereas a mutant FOXK1 does not. (A) Wild-type
FOXK1 (light line) activates a gasdermin D (GSDMD) promoter,
whereas a DNA binding–domain mutant version of FOXK1 (dark line)
does not activate transcription of luciferase. (B) Neither wild-type
FOXK1 nor mutant FOXK1 (H355A) activates the promoter of DHFR
that does not have any FOXK1-binding motifs and lacks any
detectable FOXK1 loci in its promoter. Each line is a representative
experiment with at least four replicates. Error bars are SE of the
mean. Time points were binned and averaged in 24-h windows for a
one-way ANOVA. *p < 0.05; all p values are given in Table 1.

the TSS), which contains a FOXK1-binding locus and multiple
FOXK1-binding motifs, or DHFR (DHFR-Luc, 1000 base pairs upstream of TSS), which does not have any FOXK1-binding loci in its
promoter (a locus was detected in the second intron). Both genes
are cell cycle regulated, and knockdown of GSDMD was shown
to result in a cell cycle arrest at S phase in a genome-wide siRNA
screen (Kittler et al., 2007 ). To test whether FOXK1 activates these
promoters, we overexpressed wild-type (wt) FOXK1 or FOXK1 with
a mutation in the DNA-binding domain (FOXK1 H355A), which
served as a negative control (Freddie et al., 2007). Cotransfection of
wt FOXK1 with GSDMD-Luc resulted in a significant increase in luciferase activity over time (Figure 8A; p < 0.05), whereas cotransfection of the DNA-binding-deficient mutant FOXK1 (H355A) showed
no significant change (Table 1). In contrast, FOXK1 could not activate DHFR-Luc, which lacked a FOXK1 locus in the promoter, when
cotransfected with either wt FOXK1 or FOXK1 (H355A; Figure 8B).
This shows that FOXK1 can activate the transcription of one of its
targets and demonstrates specificity by not activating the promoter
of a target gene in which the FOXK1-binding locus identified was
purely intronic. Finally, a small, 150–base pair intronic locus from
DHFR containing multiple FOXK1 motifs placed in the promoter
of pGL3-Basic failed to drive basal luciferase activity or show induction with expression of exogenous wt FOXK1 (unpublished data),
suggesting that an intronic FOXK1-binding locus alone is not
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To show that the FOXK1 genomic loci identified in our screen can
drive transcription of a luciferase reporter and can be further activated by FOXK1 overexpression, we cloned five of our genomic loci
that included only the DNA sequence from the intersection, upstream of luciferase in the absence of a basal promoter (pGL3Basic). These five loci mapped within 3000 base pairs of the TSS for
the genes TFDP1, RPS6KB1, ACAP3, Parp10, and Cep72. Loci
ranged in size from 865 (Parp10) to 1097 base pairs (ACAP3) and
contained one (RPS6KB1 and Parp10), two (TFDP1 and Cep72), or
three (ACAP3) FOXK1-binding motifs as determined by MEME
(Supplemental Figure S4). As previously mentioned, TFDP1 is an
E2F binding partner required for the G1/S transition, RPS6KB1 encodes a member of the ribosomal S6 kinase family of serine/threonine kinases that increases protein synthesis and cell proliferation
(Slattery et al., 2011), ACAP3 (also known as CENTB5) is a relatively
uncharacterized GTPase regulator associated with neurodegenerative processes (Shubina et al., 2009), Parp10 is poly(ADP-ribose)
polymerase that is phosphorylated by cdk2 in late G1 to S phase
(Chou et al., 2006), and Cep72 is a centrosomal protein with a critical role in forming a bipolar spindle (Oshimori et al., 2009). Thus
each of these proteins plays important functional roles in the cell
division cycle.
To determine whether these putative regulatory loci could
drive expression of luciferase in the absence of a basal promoter
and whether expression of exogenous FOXK1 could activate or
repress these reporter constructs, we cotransfected each into
U2OS cells along with either wt FOXK1 or FOXK1 (H355A). All
five of the reporters (TFDP1-Luc, RPS6KB1-Luc, ACAP3-Luc,
Parp10-Luc, and Cep72-luc) resulted in expression of baseline
luciferase activity in the absence of exogenous FOXK1. Four reporters (TFDP1-Luc, RPS6KB1-Luc, ACAP3-Luc, and Cep72-luc)
showed a significant increase in luciferase activity over 120 h
when cotransfected with wt FOXK1 but not with FOXK1 (H355A;
Figure 9). The peak of induction occurred between 48 and 72 h
posttransfection, and each of the four constructs showed a significant (p < 0.05) increase in luciferase activity between wt
FOXK1 and FOXK1 (H355A; Table 1). The weakest induction was
observed for Parp10-Luc, which showed a statistically significant
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FIGURE 9: Wild-type FOXK1 but not mutant FOXK1 activates cell cycle promoters that contain FOXK1-binding motifs
in live cells. FOXK1 (light line) activates the expression of luciferase from the ACAP3 (A), Cep72 (B), RPS6KB1 (C), or
TFDP1 (D) promoter. Mutant FOXK1 (dark line) does not activate expression of luciferase from these promoters.
(E) FOXK1 activates expression of the Parp10 promoter between 24 and 48 h posttransfection to a greater extent than
mutant FOXK1. Each line is a representative experiment with at least three replicates. Error bars are SE of the mean.
Time points were binned and averaged for every 24 h for a one-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.005. All
p values are given in Table 1.

difference in expression from 24 to 48 h (p = 0.004) but not from
48 to 72 h (p = 0.265).
Therefore five of the FOXK1-binding loci, including parts of the
promoter of TFDP1, are sufficient to drive basal expression of luciferase and can be further activated by overexpression of the wt
FOXK1. We find no induction when we use the DNA-binding mutant FOXK1 (H355A). In addition, the full promoter of a sixth target,
GSDMD, which contained a FOXK1 ChIP-seq locus, is also responsive to wt FOXK1 but not FOXK1 (H355A), whereas the promoter of
DHFR that did not contain a ChIP-seq locus was not responsive to
wt FOXK1, showing specificity of the effect.

DISCUSSION
Here we described a novel method to follow cell cycle progression
in live human cells with far greater precision than was previously
possible and used this to identify novel cell cycle regulators. Three
luciferase reporter constructs were used—one that monitors
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endogenous FOXM1 activity, a second driven by the human PLK1
promoter to report the G2/M phase of the cell cycle, and a third
that reports G1/S through the human E2F1 promoter. These cell
cycle–controlled DNA elements faithfully report each respective
phase of the cell cycle in synchronized U2OS cells based on the
phasing of the luciferase rhythms in relation to the synchronization
method, protein profiles, and FACS profiles after synchronization.
In addition, the Forkhead DNA-binding sites in the 6xDB reporter
can be bound by FOXM1. We used these novel reporters to show
that targeted reduction of FOXJ3 and FOXK1 expression by siRNA
in synchronous U2OS cells ablates cell cycle–dependent luciferase
activity in both reporter cell lines and confirmed the cell cycle phenotype by FACS analysis and growth curves.
In U2OS cells, FOXK1 is not cell cycle regulated at the protein
level (unpublished data). This is not unprecedented, as cyclin-dependent kinases are not cell cycle regulated at the mRNA level
(Whitfield et al., 2002), but instead their activity is regulated by their
Periodic cell cycle gene regulation
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well-characterized interactions with cyclins (Sherr, 2000). Therefore
it is entirely plausible that there is a cell cycle phase–specific activation of FOXJ3 or FOXK1 due to other posttranslational modifications such as phosphorylation or cell cycle–regulated binding partners. Pointing to a possible role of FOXK1 in the cell cycle, mouse
Mnf−/− (FoxK1) cells have dysregulated expression of cell cycle
genes, and Mnf−/− mice are ∼40% smaller than wild-type littermates
and have impaired muscle repair (Garry et al., 2000).
The ChIP-seq and gene expression data for FOXK1 allow us to
propose a mechanism for its role in the cell cycle. Our data show
that FOXK1 is required for the activation of an expansive set of cell
cycle–regulated genes, many of which, when knocked out in published siRNA screens, result in a cell cycle arrest; these include
TFDP1 and GSDMD. Thus there are numerous FOXK1 targets, any
one of which might result in a cell cycle arrest when knocked out.
Consistent with this, our attempts to rescue the FOXK1 cell cycle
arrest phenotype by overexpressing TFDP1 failed to restore cell cycle–regulated gene expression (unpublished data). This result supports the idea that a combinatorial effect resulting from the loss of
FOXK1 that includes multiple cell cycle genes results in the cell cycle
arrest we observe in our screen.
Earlier publications in different model systems showed that
FOXK1, when in a complex with the MADS-box SRF transcription
factor or Sin3B, functions as a repressor of promoter activity (Yang
et al., 2000; Freddie et al., 2007). Of interest, SRF contains a FOXK1binding locus downstream of the TTS and shows decreased expression upon FOXK1 siRNA knockdown (Supplemental Figure S6). The
repressive activity of FOXK1 when complexed with SRF is in contrast
with the data presented here, which demonstrate that in the subset
of genes analyzed, FOXK1 is an activator of transcriptional activity
(Figures 8 and 9). It is likely that FOXK1 can be either an activator or
a repressor, depending on promoter context and cell type (U2OS vs.
RD18 or 293), and this is supported by our analysis of genes associated with FOXK1 genomic loci in the FOXK1 siRNA–knockdown
time course, which shows genes with increased expression (e.g., are
likely repressed by FOXK1) and decreased expression (e.g., FOXK1
activated as shown here). A simple mechanism for this duality may
lie in the FOXK1 cofactors such as SRF, which impart a repressive
function to the complex, whereas others result in activation. Of
interest, FOXK1 does not appear to function as a pioneer factor, as
it requires SRF for efficient recruitment to the α-actin promoter or
the synthetic CArG construct (Freddie et al., 2007). This would imply
that FOXK1 is more dependent on cofactors than other FOX genes,
and its roles in gene expression may be much more varied, depending on complex composition.
Proposing a mechanism for the FOXJ3 cell cycle defect is more
challenging, as there are no ChIP-seq data available, and current
antibodies against FOXJ3 were insufficient for this purpose. The
genes that cluster with FOXJ3 suggest that it may be involved in
regulating a network of zinc finger–binding proteins that may affect
gene expression themselves. What role these may have in cell cycle
progression is unclear.
These results demonstrate that real-time luciferase assays can
greatly enhance the precision and reduce the cost associated with
the evaluation of potential novel regulators of cell cycle gene expression. This methodology will also facilitate development of synchronization protocols, as the need for sample collections at regular
intervals over multiple cell cycles is not required. Luciferase monitoring is more cost-effective than traditional time-course experiments,
fewer samples are required to achieve statistically significant data,
and multiple conditions can be tested with replicates at a single
time. With further refining, this technology may also prove to be a
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powerful tool in cancer drug assays. As a result of the assay’s nondestructive nature, using real-time luciferase assays will allow screening of compounds having a limited availability due to cost or origin
and will also allow for multiple treatments of the same cell population in one experiment.

MATERIALS AND METHODS
Cell lines
U2OS cells were passaged at 37°C in a humidity-controlled, CO2equilibrated incubator in DMEM (Life Technologies, Grand Island,
NY) culture medium (CM) containing 10% fetal bovine serum (FBS)
and 1% penicillin/streptomycin (Pen Strep). All stable lines were passaged in a selection medium (SM) of CM and 1.5 μg/ml puromycin.
Stable U2OS hE2F1, 6xDB, and PLK1 luciferase lines were generated by cotransfection of a minimal E2F1 promoter driving luciferase
(Johnson et al., 1994), a construct containing the 6xDB Forkhead
consensus site (Laoukili et al., 2005), or the human PLK1 promoter
(S119035, Switchgear Genomics, Menlo Park, CA), using 8 μg of
plasmid with 2 μg of puromycin-resistant pBABE-puro with FuGENE
6 (Roche, Indianapolis, IN). Negative control cell lines were produced with the same protocol and plasmid insertion confirmed via
PCR of the luciferase open reading frame (5′ATCCAGATCCACAACCTTCG3′; 5′AGAACTGCCTGCGTGAGATT3′).

Cell line synchronization
Thymidine-thymidine synchronizations were performed with U2OS
cells in 35-mm dishes (Corning, Lowell, MA) at 2 × 104 to 8 × 104
cells/plate. After 24 h, thymidine was added to a final concentration
of 2.5 mM. Cells were held in thymidine for 18 h, washed with 1.0 ml
of prewarmed, CO2-equilibrated, 1× phosphate-buffered saline
(PBS), followed by the addition of fresh selection media. After growth
for 8 h, 2.5 mM thymidine was added for 18 h, and cells were again
washed and released into fresh selection media. Thymidine/nocodazole synchronizations were performed with U2OS cells at 4 × 104 cells/
plate. After 24 h, cells were treated with 2.5 mM thymidine for 18 h,
washed with 1× PBS once, and released into fresh medium with
100 ng/ml nocodazole. After 12 h, medium was removed, and floating mitotic cells were collected by centrifugation.The remaining cells
were washed once with 1× PBS, and floating cells were resuspended
in fresh medium and replated with the adherent population.

Real-time bioluminescence monitoring
Synchronous U2OS cells were washed with PBS and the SM replaced with 2 ml of assay medium (phenol red–free L15 [Life Technologies], 10% FBS, 1% Pen Strep, 10 mM 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid, and 0.1 mM luciferin). Tissue culture
dishes were sealed with 38 circle #1 glass coverslips and silicone
grease and transferred to the LumiCycle (Actimetrics, Wilmette, IL)
at 36°C. Data analysis was performed with the LumiCycle Analysis
software (Actimetrics). Where indicated, data were baseline subtracted using a 24-h running average. Time zero (t = 0) indicates
time of release from cell cycle synchronization.
Promoter assays were performed by transfecting U2OS cells with
250 ng of each plasmid (see later description) using FuGENE 6 (Life
Technologies) immediately before sealing the dishes and transferring them to the LumiCycle. Where possible, each promoter
construct was placed in the LumiCycle so it would use the same
photomultiplier tube. The p values were calculated using SPSS Statistics 19 (IBM, Armonk, NY) by performing a one-way analysis of
variance (ANOVA) comparing the replicate wt FOXK1 transfections
with the mutant FOXK1 (H355A) transfections. Luciferase readings
were binned and averaged over each 24-h period.
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Plasmids
DHFR (S101166), PLK1 (S119035), and GSDMD (S112693) were
purchased from Switchgear Genomics. The FOXK1 (2256) and
DNA-binding mutant FOXK1 (2265) (Freddie et al., 2007) constructs were gifts from A. Sharrocks. 6xDB (Furuyama et al., 2000;
Laoukili et al., 2005) was a gift from R. Medema, and the minimal
hE2F promoter construct (Johnson et al., 1994) was a gift from
W. D. Cress. FOXM1-ER was subcloned from an ER fragment (gift
from M. Cole) and FOXM1-pBABE-puro, which was cloned from
human cDNA. All plasmids were sequenced to confirm that there
were no errors (Molecular Biology and Proteomics Core Facility,
Dartmouth College).
FOXK1 target promoters were cloned based on the ChIP-seq loci
as determined by MACS. Primers were designed to flank any FOXK1
motifs and to provide an amplicon between 800 and 1000 base
pairs long (Primer 3; Rozen and Skaletsky, 2000). DNA fragments
were amplified by PCR and cloned into Zero Blunt TOPO (Life
Technologies), and then they were subcloned into the MCS of pGL3basic (Promega, Madison, WI) using standard methods. All inserts
were sequenced to confirm their identity (Molecular Biology and
Proteomics Core Facility, Dartmouth College).

siRNA transfections
Cells were transfected with siRNA (100 nM) using Oligofectamine
(Life Technologies). Bioluminescence assays were performed as described, except that siRNA transfection began 24 h before the first
thymidine arrest (Supplemental Figure S1B). RNA was collected
48 h after transfection to measure knockdown efficiency of each
siRNA by Taqman quantitative RT-PCR. All siRNAs were obtained
from Dharmacon/Thermo Fisher Scientific (Lafayette, CO): FOXJ3
(#1, GGGAAAGGUUUAAGAGAAUUU; #2, GUAGGAAACUGAAA
GGAAAUU); FOXK1 (#1, GAGCAGUGGUUCUUGGAAAUU; #2,
AGAACAAUGCCAAGUGAAAUU); FOXM1 (GGACCACUUUCCCU
ACUUU; Wang et al., 2005); and siGENOME SMARTpool, human
TFDP1 (7027). Human siGENOME Non-Targeting siRNA #2 was
used as a negative control.

Western blot analysis
Antibodies to FoxM1 C-20 (1:500), cyclin B1 (H-433; 1:2000), and
E2F1 (C-20; 1:500) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA), anti–glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was purchased from American Research Products (Belmont,
MA), and anti-FOXK1 (ab18196) was purchased from Abcam (Cambridge, MA). Protein was collected from each plate in SDS–PAGE
sample buffer. Western blots were run following standard protocols.

Real-time PCR
All real-time PCRs were performed with an Applied Biosystems
(Foster City, CA) 7500 Fast Real Time PCR system using TaqMan
Fast Universal PCR Master Mix (Applied Biosystems), TaqMan
Gene Expression Assays, and 5 ng of cDNA template according
to manufacturer’s instructions in triplicate, except that all reaction
volumes were reduced by one-half. Primers used were as follows:
FOXM1, Hs00153543_m1; FOXJ3, Hs00208978_m1; FOXK1,
Hs01595620_m1; and GAPDH, 4352934E. All primers were purchased from Applied Biosystems. Real-time data were analyzed
using the 2−ΔΔCT method (Livak and Schmittgen 2001), using
GAPDH as a control.

ChIP-seq
FOXM1 chromatin immunoprecipitations were performed with
Upstate Biotechnology/Millipore (Billerica, MA) ChIP assay kit
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protocol. Primers were obtained from Life Technologies and were
as follows: 6xDB primer 1 (forward, ACGCTGTTGACGCTGTTAAG;
reverse, CGAATTCGAACACGCAGAT), 6Xdb primer 2 (forward,
CCACACGCGTCACCTTAATA; reverse, GCCCAGCGTCTTGTCATT), and GAPDH (forward, CAATTCCCCATCTCAGTCGT; reverse,
TAGTAGCCGGGCCCTACTTT).
FOXK1 ChIP-seq was carried out as previously described (Lupien
et al., 2008) using antibodies sc-133592 (G22) and sc-134550 (H140)
against FOXK1 (Santa Cruz Biotechnology). Briefly, HeLa cells were
fixed with 1% formaldehyde before the DNA was sonicated to a
fragment length of 200–600 base pairs with a Bioruptor (Diagenode, Sparta, NJ). Antibodies were bound to a mix of protein A and
protein G Dynabeads (Life Technologies) before an 18-h incubation
at 4°C with the fragmented DNA. DNA was washed and cross-links
reversed before purification with a QIAquick PCR purification kit
(Qiagen, Valencia, CA). DNA concentrations were measured using
Quant-iT PicoGreen (Life Technologies). A library was constructed
from the bound fragments per manufacturer’s protocols, and the
DNA fragments from each independent ChIP were sequenced independently at the High Throughput Sequencing Facility, University of
North Carolina at Chapel Hill (UNC; Chapel Hill, NC), using an Illumina Genome Analyzer II. Fastq files obtained from the Genome
Analyzer for each run were mapped to human genome using Bowtie
software (version 0.12.5), using the “best” flag to constrain reported
alignments to those with the fewest mismatches and best read quality. ChIP-seq of FOXK1 using AB G22 resulted in 58 million mapped
sequence reads (2.1 million unmapped), and ChIP-seq using
AB134550 resulted in 65 million mapped reads (2.2 million unmapped, Human Genome build Hg19). Enriched peaks were identified independently in each data set using MACS version 1.3.7
(Zhang et al., 2008; mfold 15, p < 0.001), which resulted in 7513
peaks in AB G22 and 6225 peaks in AB1344550. As a conservative
estimate of FOXK1 binding, we analyzed the intersection of the sequences under the peaks found in both experiments, resulting in
4329 shared FOXK1-binding loci. We determined the distribution
of these 4329 shared FOXK1-binding loci in the genome using the
Cis-regulatory Element Annotation System (CEAS; http://liulab.dfci
.harvard.edu/CEAS; Zhang et al., 2008) implemented in Cistrome
(www.cistrome.com). The full data are available from the Gene
Expression Omnibus (GEO) repository GSE39138.

Identification of cis-acting regulatory elements
The 4329 shared loci were analyzed for cis-acting regulatory motifs.
RepeatMasker Open-3.0. (www.repeatmasker.org) was used to screen
input DNA for repeats and generate a modified version of the query
sequence with masked repeats (replaced with N’s). Sequence comparisons in RepeatMasker were performed by default search engine
“cross_match” and were run with “–nolow” parameter. To analyze
masked ChIPseq data and discover significant motifs with high similarity to FOXK1 site and their potential partners, we used MEME Suite
(Bailey et al., 2009). Specifically, we analyzed sequences resulting
from the intersection of the MACS peaks from the two experiments
by MEME-ChIP (Machanick and Bailey, 2011), which is designed specifically for motif analysis in large ChIP-seq data sets. MEME-ChIP
was run via Web server with default settings except for the following:
motif distribution, any number of repetitions; optimum motif width,
6–10 base pairs; maximum number of motifs to find, 10.
To identify the best matches to known FOXK1 sites among motifs predicted by MEME-ChIP, we used STAMP (Mahony and Benos,
2007). We compared the output from MEME-ChIP to a manually
constructed database that contained a position-weight matrix that
represented the published FOXK1 motif (TAAACA; Tsai et al., 2006).
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A motif was considered to be a match to a FOXK1 site if STAMP
E value was <1 × 10−4. STAMP was run with default settings. To find
significant spacing patterns between FOXK1 matches and other
motifs predicted by MEME-ChIP, we used SpaMo (Whitington et al.,
2011). SpaMo was run in command line mode with the following
parameters: “-margin 100 -shared 1.” Motifs that formed significant
spacing patterns with FOXK1 matches were run via STAMP against
TRANSFAC, version 11.3 (Matys et al., 2003), to identify potential
FOXK1 cofactors. To extract all instances of each individual motif,
we used FIMO in command line mode with the modified p value
output threshold of 1 × 10−3.

gene to a bin, we computed the dot product of the normalized expression data for each gene to each of the eight possible ideal patterns to generate an “ideal pattern” score. We ordered each bin by
the “ideal pattern” score and displayed the data using Java TreeView
(Supplemental Figure S5).

RNA isolation and microarray hybridization

Growth curve

Asynchronous U2OS cells were transfected with siRNAs targeting
FOXJ3 or FOXK1 with Oligofectamine, following the manufacturer’s protocols. Experiments were performed in a time-course
design. Three time-zero points were collected from untransfected
cells. Time points were then harvested in parallel from the mocktransfected and the FOXJ3 and FOXK1 siRNA–transfected cells at
12, 24, 48, and 72 h after transfection. Cellular RNA was isolated
using the RNeasy Plus Kit (Qiagen). Total RNA (200 ng) was amplified using the Quick-Amp Labeling Kit (Agilent Technologies,
Santa Clara, CA) and hybridized to Agilent Technologies Whole
Human Genome Oligonucleotide arrays (4 × 44k) following the
manufacturer’s protocol, except for the labeling reaction, for
which volumes were reduced by half. Microarrays were scanned
using a GenePix 4000B scanner (Molecular Devices, Sunnyvale,
CA). Spot pixel intensities were determined by the GenePix Pro
5.1 software. Poor-quality spots were manually flagged and
excluded from further analysis. Arrays were stored in the UNC
Microarray Database.
Gene expression data were retrieved for each microarray from
the UNC microarray database. Only spots with intensity over background of >1.5 were used for further analysis. Genes missing >20%
of their data were excluded from further analysis; only genes with
three observations with a log2 absolute value of ≥1.1 (a 2.14-fold
change) across all three time-course experiments were selected.
Gene selection and hierarchical clustering were performed using
Cluster 3.0 (Eisen et al., 1998). The 24-h time point for the FOXK1
siRNA was excluded from the analysis due to a technical failure.
Data were zero transformed by normalizing each time course to the
average of the three zero time points. Data were visualized using
Java TreeView software (Saldanha, 2004).
Functional annotation of gene clusters was performed using
DAVID (Dennis et al., 2003; Huang da et al., 2009) with the following
categories: cog_ontology, sp_pir_keywords, up_seq_feature, goterm_bp_fat, BBID, Biocarta, KEGG_pathway. Only categories with
p < 0.05 are shown in Supplemental Table S1. The p values corrected for multiple hypothesis testing are also provided.
To identify genes associated with FOXK1 ChIP-seq loci that also
showed a change in expression upon FOXK1 knockdown, we normalized the expression values of genes associated with FOXK1 loci
(as determined by CEAS) to a maximum value between −1 and 1.
We then constructed “ideal patterns” of expression, where perfect
induction would have a 1 for each time point, perfect repression
would be signified by −1, and unregulated would be indicated by 0.
Because there are three expression categories and two treatment
conditions, we set up 23 = 8 bins, one per pattern. For example, the
“ideal pattern” for a gene that is repressed after FOXK1 siRNA
treatment and unregulated after mock treatment is four zeros followed by four ones (00001111). We then normalized the ideal patterns in the same way as the gene expression data. To assign each

U2OS cells expressing the E2F1 construct were plated at a density
of 6 × 106 cells/well in 12-well dishes. After 24 h of growth, 100 nM
siRNA was transfected with Oligofectamine, and three wells were
counted using trypan blue for each time point.
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FACS determination of cell cycle phase
Cell synchrony was monitored by flow cytometry of propidium iodide–stained cells (Whitfield et al., 2002). Percentage of cells in each
cell cycle phase was determined with FlowJo, version 7.5 (Tree Star,
Ashland, OR).

The full data figures in both red/green and blue/yellow formats are
available from a website maintained by the authors at http://
whitfieldlab.dartmouth.edu/lumicycle.
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